Sanket Srinivasa

Sanket Srinivasa

Auto-generated profile, based on publicly available information

Sanket Srinivasa

Department of General Surgery, North Shore Hospital, Auckland, New Zealand

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
SSS. Srinivasa
S. Srinivasa
MTM. H. G. Taylor
M. H. G. Taylor
PSP. P. Singh
P. P. Singh
TYT.‐C. Yu
T.‐C. Yu
MSMattias Soop
Mattias Soop
AHA. G. Hill
A. G. Hill

1 August 2011 in Annals of Surgery
Verified
Journal Article
Closed access
SSSanket Srinivasa
Sanket Srinivasa
AKArman A. Kahokehr
Arman A. Kahokehr
TYTzu-Chieh Yu
Tzu-Chieh Yu
AHAndrew G. Hill
Andrew G. Hill
To determine the clinical safety and efficacy of preoperative glucocorticoid (GC) administration in major abdominal surgery with regards to short term outcomes. Previous randomized controlled trials (RCTs) in major abdominal surgery have displayed conflicting results regarding the short-term benefits of preoperative GC administration. Importantly, the safety of this intervention has not been conclusively determined. A systematic review and quantitative meta-analysis was conducted of all RCTs exploring preoperative GC administration in major abdominal surgery for the endpoints of complications, hospital length of stay (LOS) and serum IL-6 on postoperative day one. Subset analyses by procedure were planned "a priori." Eleven RCTs of moderate quality, comprising 439 patients in total, were included in the final analysis. Preoperative GC use decreased complications (OR = 0.37; 95% CI, 0.21-0.64; P < 0.01), LOS (mean = 1.97 days; 95% CI, -3.33 to -0.61; P = 0.01), and serum IL-6 (mean: -55 pg/mL; 95% CI, -82.30 to -27.91; P < 0.01). Preoperative GCs decreased complications in hepatic resection (OR = 0.28; 95% CI, 0.14-0.55; P < 0.01) and mean LOS (mean LOS: -2.66; 95% CI, -5.01 to -0.32; P = 0.03). GCs reduced mean LOS in patients undergoing colorectal surgery (mean LOS: -0.98; 95% CI, -1.67 to -0.27; P = 0.01). There was no difference in complication rates (OR: 0.45; 95% CI, 0.16-1.32; P = 0.15) or anastomotic leaks specifically. Preoperative administration of GCs decreases complications and LOS after major abdominal surgery as a likely consequence of attenuating the postsurgical inflammatory response. There is no evidence of increased complications in colorectal surgery.

14 November 2013 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
SSS. Srinivasa
S. Srinivasa
DLD. P. Lemanu
D. P. Lemanu
PSP. P. Singh
P. P. Singh
MTM. H. G. Taylor
M. H. G. Taylor
AHA. G. Hill
A. G. Hill

24 September 2010 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
SSS. Srinivasa
S. Srinivasa
MTM. H. G. Taylor
M. H. G. Taylor
TST. Sammour
T. Sammour
AKA. A. Kahokehr
A. A. Kahokehr
AHA. G. Hill
A. G. Hill

4 September 2010 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
SSSanket Srinivasa
Sanket Srinivasa
LHLaura S Hill
Laura S Hill
TSTarik Sammour
Tarik Sammour
AHAndrew G Hill
Andrew G Hill
RBRichard Babor
Richard Babor
HRHabib Rahman
Habib Rahman

22 February 2013 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
SSSanket Srinivasa
Sanket Srinivasa
AKArman Kahokehr
Arman Kahokehr
MSMattias Soop
Mattias Soop
MTMatthew Taylor
Matthew Taylor
AHAndrew G Hill
Andrew G Hill
Goal-directed fluid therapy (GDFT) has been shown to reduce complications and hospital length of stay following major surgery. However, there has been no assessment regarding its use in clinical practice. An electronic survey was administered to randomly selected anaesthetists from the United Kingdom (UK, n = 2000) and the United States of America (USA, n = 2000), and 500 anaesthetists from Australia/New Zealand (AUS/NZ). Preferences, clinical use and attitudes towards GDFT were investigated. Results were collated to examine regional differences. The response rates from the UK (n = 708) and AUS/NZ (n = 180) were 35%, and 36% respectively. The response rate from the USA was very low (n = 178; 9%). GDFT use was significantly more common in the UK than in AUS/NZ (p < 0.01). The Oesophageal Doppler Monitor was the most preferred instrument in the UK (n = 362; h76%) with no clear preferences in other regions. GDFT was most commonly utilised in major abdominal surgery and for patients with significant comorbidities. The commonest reasons stated for not using GDFT were either lack of availability of monitoring tools (AUS/NZ: 57 (70%); UK: 94 (64%)) or a lack of experience with instruments (AUS/NZ: 43 (53%); UK: 51 (35%)). A subset of respondents (AUS/NZ: 22(27%); UK: 45 (30%)) felt GDFT provided no perceived benefit. Enthusiasm towards the use of GDFT in the absence of existing barriers was high. Several hypotheses were generated regarding important differences in the use of GDFT between anaesthetists from the UK and AUS/NZ. There is significant interest in utilising GDFT in clinical practice and existing barriers should be addressed.